Table 3.
Clinic and transplant characteristics in Allogeneic hematopoietic stem cell transplantation patients
| Characteristic | Low PLT (≤ 65 × 109/L) group (n = 127) | High PLT (> 65 × 109/L) group (n = 50) | P value | |
|---|---|---|---|---|
| Median patients age (range) | 39 (17–65) | 38 (18–61) | 0.725 | |
| Gender, n (%) | 0.318 | |||
| Male | 58 (45.7) | 27 (54.0) | ||
| Female | 69 (54.3) | 23 (46.0) | ||
| Type of donor, n (%) | 0.892 | |||
| MSD | 53 (41.7) | 19 (38.0) | ||
| HID | 72 (56.7) | 30 (60.0) | ||
| MUD | 2 (1.6) | 1 (2.0) | ||
| Stem cell source, n (%) | 0.219 | |||
| PBSC | 48 (37.8) | 14 (28.0) | ||
| PBSC + BM | 79 (62.2) | 36 (72.0) | ||
| Conditioning regimen, n (%) | 0.212 | |||
| Bu-Cy | 91 (71.6) | 31 (62.0) | ||
| Bu-Flu | 36 (28.4) | 19 (38.0) | ||
| GVHD prophylaxis, n (%) | 0.863 | |||
| CsA + MTX | 53 (41.7) | 19 (38.0) | ||
| CsA + MTX + ATG | 6 (4.7) | 2 (4.0) | ||
| CsA + MTX + ATG + MMF | 68 (53.6) | 29 (58.0) | ||
MSD HLA-matched sibling donor, MUD HLA-matched unrelated donor, HID haploidentical related donors, PBSC peripheral blood stem cell, BM bone morrow, Bu busulfan, Cy cyclophosphamide, Flu fludarabine, GVHD graft-versus-host disease, CsA cyclosporine A, MTX methotrexate, ATG antithymocyte globulin, MMF mycophenolate